Showing results (21-30 of 115) with videos related to
Sort By:
Pageof 12
Cancer Chemotherapy and Pharmacology|January 1, 1988
Very high-dose cisplatin-induced ototoxicity: a preliminary report on early and long-term effectsC F Pollera, P Marolla, M Nardi, et al.American Journal of Clinical Oncology|December 1, 1989
Effective control of CMF-related emesis with high-dose dexamethasone: results of a double-blind crossover trial with metoclopramide and placeboC F Pollera, M Nardi, P Marolla, et al.Oncology|January 1, 1990
Dose and schedule effects of cisplatin on the related acute iron changesC F Pollera, F Ameglio, M Nardi, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
Changes in serum iron levels following very high-dose cisplatinC F Pollera, F Ameglio, S Reina, et al.Journal of Experimental & Clinical Cancer Research : CR|May 20, 2004
The combination of carboplatin and weekly paclitaxel: a safe and active regimen in advanced non small-cell lung cancer patients. A phase I-II studyA Fabi, M Barduagni, V Ferraresi, et al.Pathologica|February 1, 1994
[Liver lipoma. Anatomo-histologic and radiologic study]A Scapati, C Scapati, S De Marco, et al.Journal of Experimental & Clinical Cancer Research : CR|June 7, 2000
Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overviewL Serrone, M Zeuli, F M Sega, et al.Cancer Chemotherapy and Pharmacology|April 26, 2001
A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential scheduleL Serrone, M Zeuli, T Gamucci, et al.Journal of Experimental & Clinical Cancer Research : CR|August 1, 2002
Salvage chemotherapy for advanced sarcoma patients: a single-institution experience surveyL Serrone, C Nardoni, A Gelibter, et al.Cancer Investigation|January 1, 1994
High dose-intense chemotherapy alone or in combination with interleukin-2 for small cell lung cancer: a pilot studyC F Pollera, F Calabresi, M Moreschi, et al.Pageof 12